Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs (Q47791673)

5 February 2018

title

Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs (English)

1 reference

5 February 2018

author name string

Catherine M Tone

1

1 reference

5 February 2018

Dawn M Cardoza

2

1 reference

5 February 2018

Robert H Carpenter

3

1 reference

5 February 2018

Ruxandra Draghia-Akli

4

1 reference

5 February 2018

publication date

1 May 2004

1 reference

5 February 2018

published in

Cancer Gene Therapy

1 reference

5 February 2018

volume

11

1 reference

5 February 2018

issue

5

1 reference

5 February 2018

page(s)

389-396

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1038/sj.cgt.7700717

exact match

0 references

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Effect of short-term recombinant growth hormone administration on plasma lipoproteins in elderly adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Effects of plasmid-mediated growth hormone releasing hormone supplementation in young, healthy Beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Synthetic muscle promoters: activities exceeding naturally occurring regulatory sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Myogenic expression of an injectable protease-resistant growth hormone-releasing hormone augments long-term growth in pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Persistence and expression of the adenosine deaminase gene for 12 years and immune reaction to gene transfer components: long-term results of the first clinical gene therapy trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Gene therapy for the treatment of hemophilia B using PINC-formulated plasmid delivered to muscle with electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Gene electrotransfer: potential for gene therapy of renal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Attenuated acute liver injury in mice by naked hepatocyte growth factor gene transfer into skeletal muscle with electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Pharmacological and toxicological effects of chronic porcine growth hormone administration in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Growth hormone therapy and its relationship to insulin resistance, glucose intolerance and diabetes mellitus: a review of recent evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Effects of insulin-like growth factor-I deficiency and replacement therapy on the hematopoietic system in patients with Laron syndrome (primary growth hormone insensitivity).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

The influence of growth hormone substitution therapy on erythroid and myeloid progenitor cells and on peripheral blood cells in adult patients with growth hormone deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

Nonclinical toxicology in support of licensure of gene therapies. Arlington, VA, USA, March 13-14, 2003

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

7 January 2021

Provision of rhIGF-I/IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

7 January 2021

Treatment of cachexia with recombinant growth hormone in a patient before lung transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

7 January 2021

Effect of chronic growth hormone administration on skeletal muscle in dogs

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

7 January 2021

Differences in the effects of 20 K- and 22 K-hGH on water retention in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

7 January 2021

Effects of plasmid-mediated growth hormone-releasing hormone in severely debilitated dogs with cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

7 January 2021

Electrical enhancement of formulated plasmid delivery in animals

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

7 January 2021

AAV-mediated gene transfer for hemophilia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

7 January 2021

Enhancement of antitumor effect of bleomycin by low-voltage in vivo electroporation: a study of human uterine leiomyosarcomas in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

7 January 2021

Increase in haemoglobin concentrations in growth hormone deficient adults during human recombinant growth hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CGT.7700717

7 January 2021

Identifiers

DOI

10.1038/SJ.CGT.7700717

1 reference

5 February 2018

PubMed ID

15073611

1 reference

5 February 2018